ENDRA Life Sciences Market Cap 2011-2026 | NDRA

As of April 27, 2026 ENDRA Life Sciences has a market cap of $ 3.78 M

Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.^[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap ENDRA Life Sciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.66 M	829 K	3.44 K	11.6 M	911 K	36.5 M	11.2 M	9.82 M	9.37 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
36.5 M	3.44 K	9.33 M

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Diagnostics research industry

Issuer	Market Cap	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	221 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	42 B	$ 115.62	0.06 %	$ 35.1 B	USA
Akumin AKU	75.1 M	-	-17.87 %	$ 25.9 M	Canada
Illumina ILMN	16.4 B	$ 128.52	0.5 %	$ 20.4 B	USA
Accelerate Diagnostics AXDX	40.3 M	-	-61.36 %	$ 2.46 M	USA
Co-Diagnostics CODX	5.85 M	$ 1.65	-1.2 %	$ 2.19 M	USA
Aspira Women's Health AWH	45.4 M	-	-6.19 %	$ 10.5 M	USA
Lantheus Holdings LNTH	5.12 B	$ 84.11	-0.26 %	$ 5.68 B	USA
Medpace Holdings MEDP	13 B	$ 421.37	2.64 %	$ 12.2 B	USA
Biocept BIOC	5.93 M	-	-13.05 %	$ 7.29 M	USA
Castle Biosciences CSTL	709 M	$ 24.98	2.13 %	$ 694 M	USA
Chembio Diagnostics CEMI	12.6 M	-	0.22 %	$ 16.8 M	USA
Koninklijke Philips N.V. PHG	30.8 B	$ 27.54	0.25 %	$ 20 B	Niderland
Check-Cap Ltd. CHEK	4.33 M	-	-	$ 9.42 M	Israel
Personalis PSNL	254 M	$ 5.96	-2.3 %	$ 353 M	USA
CareDx, Inc CDNA	993 M	$ 21.85	2.92 %	$ 1.16 B	USA
Oxford Immunotec Global PLC OXFD	421 M	-	-	$ 562 M	Britain
Senseonics Holdings SENS	351 M	$ 7.27	3.12 %	$ 303 M	USA
Soleno Therapeutics SLNO	2.08 B	$ 52.75	0.06 %	$ 2.68 B	USA
DermTech DMTK	42.4 M	-	-11.32 %	$ 2.94 M	USA
Enzo Biochem ENZ	57.5 K	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	19.5 B	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	467 M	$ 15.6	-4.35 %	$ 472 M	USA
Global Cord Blood Corporation CO	243 M	-	-	$ 399 M	China
Thermo Fisher Scientific TMO	196 B	$ 468.04	-0.36 %	$ 176 B	USA
Fluidigm Corporation FLDM	481 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	9.22 B	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	1.54 B	-	0.12 %	$ 80.1 M	China
Trinity Biotech plc TRIB	120 M	$ 0.64	-0.82 %	$ 61.9 M	Irlanda
Charles River Laboratories International CRL	7.69 B	$ 171.23	0.86 %	$ 8.49 B	USA
PRA Health Sciences, Inc. PRAH	7.87 B	-	-	$ 10.7 B	USA
Twist Bioscience Corporation TWST	1.56 B	$ 61.0	0.1 %	$ 3.65 B	USA
Guardant Health GH	13.4 B	$ 88.5	-0.46 %	$ 11.1 B	USA
HTG Molecular Diagnostics HTGM	2.99 M	-	-20.0 %	$ 1.06 M	USA
Heska Corporation HSKA	844 M	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	7.34 M	-	-	$ 8.54 M	USA
Motus GI Holdings MOTS	990 K	-	-34.28 %	$ 263 K	Israel
QIAGEN N.V. QGEN	8.52 B	-	-	$ 10.6 B	Niderland
Neogen Corporation NEOG	1.02 B	$ 9.45	-0.94 %	$ 2.05 B	USA
Biomerica BMRA	7.19 M	$ 2.18	1.87 %	$ 5.01 M	USA
National Research Corporation NRC	315 M	$ 17.11	-0.7 %	$ 383 M	USA
ICON Public Limited Company ICLR	16.6 B	$ 103.21	1.02 %	$ 8.51 B	Irlanda
Laboratory Corporation of America Holdings LH	23.9 B	$ 263.43	-0.14 %	$ 21.9 B	USA
Celcuity CELC	5.37 B	$ 125.68	3.84 %	$ 5.88 B	USA
OpGen OPGN	9.12 M	-	-16.95 %	$ 1.54 M	USA
NeoGenomics NEO	1.48 B	$ 8.61	3.86 %	$ 1.1 B	USA
Myriad Genetics MYGN	409 M	$ 4.83	1.05 %	$ 447 M	USA
Natera NTRA	5.31 B	$ 204.46	0.35 %	$ 20.1 B	USA
Quest Diagnostics Incorporated DGX	23.3 B	$ 196.63	0.18 %	$ 21.8 B	USA
Invitae Corporation NVTA	511 M	-	-	$ 21.2 M	USA